CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Aquestive Therapeutics, Inc. formerly Monosol RX, LLC vs. Neurelis, Inc.

Explore the PTAB proceeding IPR2019-00450 filed by Aquestive Therapeutics, Inc. formerly Monosol RX, LLC on 2019-01-29. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2019-00450

Filing Date

2019-01-29

Accorded Filing Date

2019-02-06

Institution Decision Date

2019-08-01

Last Modified Date

2022-10-10

Proceeding Type

IPR

Termination Date

โ€”

Trial Status

Institution Denied

Parties & Counsel

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 14527613
Respondent Patent Number 9763876
Legal Expiration Date
2029-04-13 Active (2.4 yrs remaining)
Injunction Viability (35 U.S.C. ยง 283) Active Threat
Respondent Inventor Steve Cartt et al
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

0 Total

Proceeding Status

Institution Denied

Administrative Patent Judges (APJ Panel)

Panel assignment tracked upon institution decision entry

Address and Attorney/Agent Information

22 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name DLA Piper LLP (US)/Pittsburgh
Customer Number 185628
Address 1650 Market Street, Suite 5000, Philadelphia, PA, 19103, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
31750 Thomas Christenbury +1 215-656-3381
37878 Jill Mandelblatt +1 215-656-2482
38347 Lisa Haile +1 858-677-1456
42891 Raymond Miller +1 412-454-5000
42982 Michael Patane +1 609-505-8283
50229 Nancy Endejann +1 215-656-2490
54163 Joseph Helmsen +1 215-656-2480
54981 William Bartow +1 215-656-2458

Global Patent Family Cross-Litigation Radar

CasLoc 360ยฐ Radar 10 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

๐Ÿ‡บ๐Ÿ‡ธ
U.S. District Courts Counterparts in force
๐Ÿ›๏ธ
USPTO PTAB Trials 3 proceedings
๐Ÿ‡ช๐Ÿ‡บ
Unified Patent Court (UPC) Counterparts in force
๐Ÿ‡ฉ๐Ÿ‡ช
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (10): ๐Ÿ‡บ๐Ÿ‡ธ US
Parallel Proceedings Across Jurisdictions (3 found):
PTAB: 3
USPTO PTAB Trial 2025-01-17
IPR2025-00464

Padagis US LLC et al. v. Neurelis, Inc.

U.S. Continuation Sibling (8895546)
Status: Terminated-Settled
USPTO PTAB Trial 2019-01-29
IPR2019-00451

Aquestive Therapeutics, Inc. formerly Monosol RX, LLC v. Neurelis, Inc.

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2019-01-28
IPR2019-00449

Aquestive Therapeutics, Inc. formerly Monosol RX, LLC v. Neurelis, Inc.

Asserted Patent
Status: Institution Denied
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

82
10

Notice of Refund Paper

2019-11-18 FILING PARTY: BOARD
9

PETITIONER'S REQUEST FOR REFUND OF POST INSTITUTION FEES Paper

2019-11-07 FILING PARTY: PETITIONER
8

Decision Denying Institution of Inter Partes Review Paper

2019-08-01 FILING PARTY: BOARD
7

Patent Owner's Mandatory Notices Paper

2019-05-21 FILING PARTY: PATENT OWN
2005

K.M. Fiest et al., Prevalence and Incidence of Epilepsy, A Systematic Review and Meta-Analysis of International Studies, 88 Neurology 296 (17 Jan. 2017) Exhibits

2019-05-06 FILING PARTY: PATENT OWN

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc